NCT05480527

Brief Summary

Investigators want to investigate the efficacy of transcutaneous pulsed radiofrequency therapy in the treatment of diabetic peripheral neuropathy symptoms. For this purpose, investigators aimed to compare the results of two groups treated with sham electrode and active electrode.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2021

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

July 27, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 29, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

May 16, 2023

Status Verified

February 1, 2023

Enrollment Period

1.9 years

First QC Date

July 27, 2022

Last Update Submit

May 15, 2023

Conditions

Keywords

neuropathic paintranscutaneous pulsed radiofrequency

Outcome Measures

Primary Outcomes (1)

  • Change from baselina in pain on the Visual Analog Scale (VAS) at week 4 and 12

    The visual analogue scale (VAS) is a scale that can be used measuring pain. Scores range from 0 (no pain) to 10 (the worst pain).

    Bseline, week 4 and week 12

Secondary Outcomes (1)

  • Self-Administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS)

    baseline, week4 and week 12

Study Arms (2)

Patients with bilateral neuropathic pain which treating active electrode

ACTIVE COMPARATOR

30 patients which treating with transcutaneous pulsed radiofrequency. All patients have diabetic polyneuropathy and confirmed with electroneuromyography.

Device: Transcutaneous pulsed radiofrequency current

Patients with bilateral neuropathic pain which applied sham electrode

SHAM COMPARATOR

Sham electrodes will be applied to 30 patients. All patients have diabetic polyneuropathy and confirmed with electroneuromyography.

Device: Transcutaneous pulsed radiofrequency current

Interventions

Active treating group: 80 volts, 2Hz, 20 ms pulsed radiofrequency current will be applied to the tibial nerve trace in the ankle with electrodes. Sham group: Elelctrodes will be attached but radiofrequency current will not be applied.

Patients with bilateral neuropathic pain which applied sham electrodePatients with bilateral neuropathic pain which treating active electrode

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of Diabetes Mellitus
  • Peripheric neuropathy with proved electroneuromyography

You may not qualify if:

  • Additional endocrinological disease,
  • Pregnancy, malignancy, motor deficit in lower extremities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dişkapi Reserch and Education Hospital

Ankara, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

NeuritisNeuralgia

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mehlika Panpallı Ateş

    Diskapi Yildirim Beyazit Education and Research Hospital

    STUDY CHAIR
  • Damla Yürük

    Diskapi Yildirim Beyazit Education and Research Hospital

    STUDY CHAIR
  • Ömer Taylan Akkaya

    Diskapi Yildirim Beyazit Education and Research Hospital

    STUDY DIRECTOR

Central Study Contacts

Gevher Rabia Genc Perdecioglu

CONTACT

Mehlika Panpallı Ateş

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, medical doctor

Study Record Dates

First Submitted

July 27, 2022

First Posted

July 29, 2022

Study Start

December 1, 2021

Primary Completion

November 1, 2023

Study Completion

December 1, 2023

Last Updated

May 16, 2023

Record last verified: 2023-02

Locations